These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 19787558

  • 1. Antithrombotic prophylaxis in elderly patients with atrial fibrillation.
    Hylek EM.
    Semin Thromb Hemost; 2009 Sep; 35(6):548-53. PubMed ID: 19787558
    [Abstract] [Full Text] [Related]

  • 2. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [Abstract] [Full Text] [Related]

  • 3. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ, Cheng MH, Lee CH, Wung DC, Cheng CL, Kao Yang YH.
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [Abstract] [Full Text] [Related]

  • 4. Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study.
    ROCKET AF Study InvestigatorsDuke Clinical Research Institute, Durham, NC, USA..
    Am Heart J; 2010 Mar; 159(3):340-347.e1. PubMed ID: 20211293
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. New pharmacotherapy for stroke prevention in atrial fibrillation: update 2010.
    Armaganijan L, Eikelboom J, Healey JS, Morillo CA.
    Adv Ther; 2009 Dec; 26(12):1058-71. PubMed ID: 20127214
    [Abstract] [Full Text] [Related]

  • 9. Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.
    Garwood CL, Corbett TL.
    Ann Pharmacother; 2008 Apr; 42(4):523-32. PubMed ID: 18334606
    [Abstract] [Full Text] [Related]

  • 10. Antithrombotic therapies for stroke prevention in atrial fibrillation.
    Economides Muñoz C, Singh BN.
    Minerva Cardioangiol; 2004 Apr; 52(2):125-39. PubMed ID: 15194994
    [Abstract] [Full Text] [Related]

  • 11. Newly detected atrial fibrillation and compliance with antithrombotic guidelines.
    Glazer NL, Dublin S, Smith NL, French B, Jackson LA, Hrachovec JB, Siscovick DS, Psaty BM, Heckbert SR.
    Arch Intern Med; 2007 Feb 12; 167(3):246-52. PubMed ID: 17296879
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
    Arch Intern Med; 1996 Feb 26; 156(4):409-16. PubMed ID: 8607726
    [Abstract] [Full Text] [Related]

  • 14. Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation.
    Rockson SG, Albers GW.
    J Am Coll Cardiol; 2004 Mar 17; 43(6):929-35. PubMed ID: 15028346
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of anticoagulation for stroke prevention and risk stratification in atrial fibrillation: translating trials into clinical practice.
    Go AS.
    Am J Manag Care; 2004 Apr 17; 10(3 Suppl):S58-65. PubMed ID: 15152747
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation.
    Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S.
    Circulation; 2007 May 29; 115(21):2689-96. PubMed ID: 17515465
    [Abstract] [Full Text] [Related]

  • 19. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM.
    Thromb Haemost; 2008 Jul 29; 100(1):16-7. PubMed ID: 18612532
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.